Identification of the UDI-6 and the IIQ-7 Cutoff Scores in Urinary Incontinent Women
NCT ID: NCT04433715
Last Updated: 2020-06-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
155 participants
OBSERVATIONAL
2016-03-01
2016-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods The study involved 205 women aged between 31 and 83 years - 155 with, and 50 without UI symptoms. All participants completed all three questionnaires: ICIQ-SF, UDI-6 and IIQ-7. Patients were categorized according to their ICIQ-SF scores, as symptomatic ICIQ-SF ≥6 (n=134) and asymptomatic ICIQ \< 6 (n=60). The Receiver Operating Characteristics (ROC) curve was used to test how well UDI-6 allowed a discrimination between patients suffering from UI and those who do not. AUC (Area under Curve) statistic was calculated to measure the UDI-6 and IIQ-7 Total Score efficiency.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identifying Stress Urinary Incontinence in Women With Pelvic Organ Prolapse
NCT03005977
Evident, Occult and no Demonstrated USI and UDS Findings in Women With ≥Stage II Cystocele
NCT03613311
To Use the Combined Version of ICIQ-SF and Quality of Life Scale in Mixed Urinary Incontinence
NCT05948397
Prevalence Rates of USI, BO, DO and Their Clinical and Urodynamic Findings in Women With ≥Stage II Cystocele
NCT03613350
Effectiveness of a Hip Abductor Training in Women With Stress Urinary Incontinence
NCT05635175
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods The study involved 205 women aged between 31 and 83 years - 155 with, and 50 without UI symptoms. All participants completed all three questionnaires: ICIQ-SF, UDI-6 and IIQ-7. Patients were categorized according to their ICIQ-SF scores, as symptomatic ICIQ-SF ≥6 (n=134) and asymptomatic ICIQ \< 6 (n=60). The Receiver Operating Characteristics (ROC) curve was used to test how well UDI-6 allowed a discrimination between patients suffering from UI and those who do not. AUC (Area under Curve) statistic was calculated to measure the UDI-6 and IIQ-7 Total Score efficiency.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with UI symptoms
All participants completed all three questionnaires: ICIQ-SF, UDI-6 and IIQ-7.
ICIQ-SF
All participants completed ICIQ-SF,
UDI-6
All participants completed UDI-6
IIQ-7
All participants completed IIQ-7
patients without UI symptoms
All participants completed all three questionnaires: ICIQ-SF, UDI-6 and IIQ-7.
ICIQ-SF
All participants completed ICIQ-SF,
UDI-6
All participants completed UDI-6
IIQ-7
All participants completed IIQ-7
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ICIQ-SF
All participants completed ICIQ-SF,
UDI-6
All participants completed UDI-6
IIQ-7
All participants completed IIQ-7
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
31 Years
83 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Lublin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katarzyna Skorupska
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tomasz Rechberger
Role: STUDY_DIRECTOR
Medical University of Lublin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Katarzyna Skorupska
Lublin, , Poland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Skorupska K, Grzybowska ME, Kubik-Komar A, Rechberger T, Miotla P. Identification of the Urogenital Distress Inventory-6 and the Incontinence Impact Questionnaire-7 cutoff scores in urinary incontinent women. Health Qual Life Outcomes. 2021 Mar 16;19(1):87. doi: 10.1186/s12955-021-01721-z.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.